Click here to check the ultimate guide to learn how to leverage your PC and internet to make money online.
The Washington Independent
The Washington Independent

GOP Wary of Obama Health Care Research Push

A battle is brewing over a plan to rein in medical spending by weeding out ineffective treatments.

Iram Martins
Last updated: Jul 31, 2020 | Mar 11, 2009

OMB Director Peter Orszag (WDCpix)
OMB Director Peter Orszag (WDCpix)

As congressional lawmakers continue the thorny task of crafting the sweeping health care reforms they hope to pass this year, there’s a battle brewing over the growing push to rein in medical spending by weeding out ineffective treatments.

That seemingly innocuous strategy — dubbed comparative effectiveness — relies upon research comparing different treatments for the same ailment to uncover which work best. The measure is a key component of the Obama administration’s efforts to overhaul the nation’s broken health care system and control skyrocketing medical spending — both public and private. But some powerful lawmakers, particularly on the Republican side of the aisle, are voicing fears that comparative effectiveness research could lead to restrictions in patients’ access to care by tempting Medicare and private insurers to use the data to deny coverage of certain drugs, devices and other treatments.

Illustration by: Matt Mahurin
Illustration by: Matt Mahurin

Sen. Charles Grassley (R-Iowa) said Tuesday that no one other than doctors and patients should be empowered to make individual treatment decisions.

“I support making sure that patients and doctors have up-to-date and effective information,” Grassley, the highest ranking Republican on the Senate Finance Committee, said during a hearing on health care reform. “But I would doubt support for reforms that allow some government bureaucrat to interfere with a doctor’s ability to practice medicine.”

The debate is heating up in the wake of passage of the $787 billion economic stimulus package, which provided more than $1 billion for comparative effectiveness research, and created a federal board of clinical experts to oversee it. More recently, the Obama administration introduced it’s 2010 budget blueprint, which includes a $634 billion “down-payment” on health care reform. A White House summary of the budget outline vows continued support for comparative effectiveness to “form the basis for clinical decision support tools.”

While the ultimate purpose of the comparative effectiveness research is to create a more efficient — and ultimately less expensive — health care system, the White House has been careful not to dictate how the data will be used. Appearing before the Finance Committee Tuesday, Peter Orszag, director of the Obama administration’s Office of Budget and Management, largely evaded the question.

“At the extreme,” Orszag said, “if something is shown not to be effective, it could simply not be covered. But there also are a lot of, you know, less extreme ways of guiding medical practice, for example, simply paying more for the things that work than the things that don’t … It doesn’t need to be a simple on-off switch.”

Asked by Sen. Jon Kyl (R-Ariz.) if the administration has a position on whether the comparative effectiveness board should be empowered to make reimbursement decisions, Orszag said, “Not at this point.”

That response will likely fuel the concerns of Republicans and some powerful health care industries — including the pharmaceutical and medical device manufacturers — that comparative effectiveness could be a slippery slope to rationing care. Wanda Moebius, spokeswoman for the Advanced Medical Technology Association, a medical device trade group, said the organization supports comparative effectiveness as a clinical study, but worries that cost considerations could take precedent over the unique needs of individual patients.

AdvaMed, Moebius said, “wants to ensure that cheaper doesn’t mean inferior.”

David Merritt, project director at the Center for Health Transformation, a Washington-based policy shop founded by former GOP Speaker of the House Newt Gingrich, echoed that concern, arguing that lawmakers “have to be careful about prioritizing cost effectiveness over clinical effectiveness.”

Robert Blendon, a professor of health policy at Harvard University, said much of that concern comes with one eye on a controversial British institute, which does have the power to deny coverage options based on price. Blendon, an expert* on the Clinton administration’s failed 1993 attempt to revamp the nation’s health care system, supports the research in hopes that doctors, hospitals and other providers will use the information voluntarily to improve health outcomes and, ultimately, eliminate unecessary costs.

“Give people lots of information and see what they do,” he said.

Kathleen Stoll, deputy director of Families USA, a health care consumer group, said the comparative effectiveness debate is so young that concerns about pricing reform are unfounded. “We’re simply talking about pulling the scientific research together,” Stoll said. “It’s not about rationing care, it’s about improving the quality of care.”

Few dispute that something must be done to rein in the nation’s health care costs. In 2009 alone, medical spending nationwide is projected to hit $2.6 trillion, or 18 percent of the gross domestic product, according to the Congressional Budget Office. Within eight years, it will represent 20 percent of GDP. Over the next decade, health care spending is expected to grow by 6.2 percent each year — a rate far higher than incomes and inflation.

The trend is putting a squeeze on budgets at the individual, state and federal levels. CBO projects that the cost to fund Medicare, Medicaid and the State Children’s Health Insurance Program will hit $720 billion this year.

But not all regions spend the same. A well-regarded Dartmouth University study reveals vast regional variations in per patient medical spending, largely because doctors in different parts of the country have adopted different prescribing habits. Importantly, patients in the areas of higher spending are no better off for receiving more treatments.

“The explanation,” Orszag said, “is that in those parts of the country with higher costs, there are more procedures done, more days in hospital, more tests, and what have you — none of which seems to actually improve health outcomes. And that is the key takeaway. If you look at outcomes in quality, the higher-cost states, the higher-cost hospitals, the higher-cost doctors do not produce better outcomes than the more efficient providers.”

Within those discrepancies, Orszag said, the potential for savings is enormous. If health treatment trends nationwide were matched up with those of the lower-spending regions, Orszag said, the country could save $700 billion on medical expenses each year.

But it won’t be easy. Orszag himself has indicated that the initial costs of comparative effectiveness are substantial and the benefits are years away. In a 2007 letter to lawmakers for example, Orszag, then-director of the Congressional Budget Office, wrote that “getting to the point where additional research on comparative effectiveness could have a significant impact on health spending would probably take many years.”

“In addition to the time required to get such research under way,” he added, “a lag would exist before results were generated — particularly if they depended upon new clinical trials. Initially, the available results would probably address a relatively small number of medical treatments and procedures; more time would have to elapse before a substantial body of results was amassed.”

Sen. Max Baucus (D-Mont.), chairman of the Finance Committee, pointed out another impediment to efforts to control high regional spending: the states that currently receive the most money will likely not cede it easily.

“Some of the states are getting a lot of money [and] they’re not going to want to give up,” Baucus said.

Baucus and Grassley have laid out a plan to pass a comprehensive health care reform bill through the Finance Committee in June, with hopes of getting it on Obama’s desk before summer’s end.

Blendon, of Harvard, predicted that health reform in some shape will become law this year. The public, he said, is ready for a larger federal role in providing care, and the recession has pinched pocketbooks around the country. Blendon warned, however, that the sinking economy might also interrupt the health care debate, forcing Democrats to move a lesser bill than they’d hoped.

“The idea of a bigger government role is not in question,” said Blendon. “The wildcard is the state of the economy.”

*Clarification: An earlier version of this story said Blendon was an architect of the Clinton’s health reform plan, which is not the case.

Iram Martins | Personal trainer. Aspiring sommelier. Brunch critic who works part-time. When I'm not competing, you'll find me at dog beaches with my black lab or sipping drinks at the best bars in town. I like to fly a lot.


EPA Administrator Addresses Concerns About Oil Spill Waste Management

At a hearing of the national oil spill commission today, Environmental Protection Agency Administrator Lisa Jackson addressed concerns about waste disposal from

EPA administrator defends allowing Florida to write its own water pollution rules

The EPA seal (Pic via The Environmental Protection Agency has come under fire for its decision to allow the state of Florida to write its own water pollution rules (known as “numeric nutrient criteria”). EPA Regional Administrator Gwendolyn Keyes Fleming is now firing back, writing that the Agency commends the state Department of Environmental Protection for its draft of a proposed standard. A host of environmental groups filed suit in 2008, seeking to compel the EPA to implement a strict set of water pollution standards in Florida, arguing that the state was in violation of the Clean Water Act.

E-Verify Mandate Begins Today

The Obama administration today begins implementation of a new mandate to require all federal contractors to check the legal status of their employees to confirm

EPA administrator fires back at critics in op-ed

EPA Administrator Lisa Jackson (Pic by USACEpublicaffairs, via Flickr) EPA Administrator Lisa Jackson penned a new op-ed for the Los Angeles Times , criticizing House Republicans desperately seeking to undermine the authority of the agency they have dubbed a “job killer.” Arguing that the environment affects red states and blue states alike, Jackson writes that “it is time for House Republicans to stop politicizing our air and water.” As head of the Environmental Protection Agency, Jackson has faced harsh criticism from House Republicans and GOP presidential candidates who say the agency’s regulations are an undue burden on businesses that have to cut jobs simply to comply with clean water and air rules. Presidential hopeful Michele Bachmann  has pledged to end the EPA if she takes office. “Since the beginning of this year, Republicans in the House have averaged roughly a vote every day the chamber has been in session to undermine the Environmental Protection Agency and our nation’s environmental laws,” writes Jackson.

EPA administrator says federal nutrient criteria is a ‘myth’

In testimony given late last week, EPA Administrator Lisa Jackson said that false accusations about her agency’s numeric nutrient criteria to govern Florida waterways are proving to be a detriment to their implementation. # Testifying before the House Agriculture Committee, Jackson said her agency’s work was often “mischaracterized” and addressed several myths surrounding its work

EPA and California Near Deal on Fuel Efficiency Standards

Two weeks ago, the Obama administration raised fuel efficiency standards by an average of two miles per gallon -- a modest change that disappointed some

EPA: BP Has 24 Hours to Find a Less Toxic Chemical Dispersant

Thought the massive quantities of oil pouring into the Gulf of Mexico were the only major threat to the country’s southeast coastal waters right now? Think

EPA announces hold on nutrient standards if Florida can come up with own criteria

The EPA announced today that it is now prepared to withdraw a portion of its proposed numeric nutrient criteria (a set of standards governing water pollution in inland waters) and delay the portion related to estuarine waters, to allow the state Department of Environmental Protection to develop its own criteria. # From a statement released by the EPA earlier today: # EPA recognizes that states have the primary role in establishing and implementing water quality standards for their waters. Therefore, EPA is prepared to withdraw the federal inland standards and delay the estuarine standards if FDEP adopts, and EPA approves, their own protective and scientifically sound numeric standards

EPA Chief Overruled Calif. Waiver, Too

The Washington Post reported in March that EPA Administrator Stephen Johnson was overruled by the White House in setting an ozone standard. Now, documents

© Copyright 2022 The Washington Independent All Rights Reserved

Terms & Privacy |

Click here to check the ultimate guide to learn how to leverage your PC and internet to make money online.